参考文献

    1 Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol, 2004, 49:131-157.

    2 Davis JL. Differential diagnosis of CMV retinitis. Ocul Immunol Inflamm, 1999, 7(3-4):159-166.

    3 Skiest DJ, Chiller T, Chiller K, et al. Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis. Int J STD AIDS, 2001, 12:659-664.

    4 Reed JB, Briggs JW, Mcdonald JC, et al. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis. Retina, 2001, 21(4): 339-343.

    5 李太生，邱志峰，王爱霞，等. T淋巴细胞激活亚群在HIV感染中的变化及其临床意义. 中华传染病杂志, 2002, 20(4):199-202.

    6 CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults[J]. MMWR, 1992,41(no.RR-17).

    7 Hoover DR, Peng X. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol, 1996, 114:821-827.

    8 Callant JE, More RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with zidovudine: the zidovudine study group. Infect Dis, 1992, 166:1223-1227.

    9 Holland GN. Survival od patients with the acquired immunodeficiency syndrome after development of CMV retinopathy. Ophthalmology, 1990, 97:204-210.

上一页  [1] [2] [3]